Biochemical recurrence of prostate cancer.
Moul
Judd W
JW
Department of Surgery, Uniformed Services University of the Health Services, Bethesda, Maryland, USA.
D000726:Androgen Antagonists / Q000627:therapeutic use; D000813:Anilides / Q000627:therapeutic use; D004791:Enzyme Inhibitors / Q000627:therapeutic use; D018120:Finasteride / Q000627:therapeutic use; D005485:Flutamide / Q000627:therapeutic use; D006801:Humans; D008297:Male; D009362:Neoplasm Metastasis; D009364:Neoplasm Recurrence, Local / Q000175:diagnosis* / Q000188:drug therapy* / Q000532:radiotherapy; D009570:Nitriles; D017430:Prostate-Specific Antigen / Q000737:chemistry; D011468:Prostatectomy; D011471:Prostatic Neoplasms / Q000175:diagnosis* / Q000188:drug therapy* / Q000532:radiotherapy / Q000601:surgery; D014105:Tosyl Compounds
D000726:Androgen Antagonists; D000813:Anilides; D004791:Enzyme Inhibitors; D009570:Nitriles; D014105:Tosyl Compounds; D018120:Finasteride; D005485:Flutamide; C053541:bicalutamide; D017430:Prostate-Specific Antigen